Finance

Lists
RYM:NZE
Ryman Healthcare Ltd
1,76 NZ$
-1,40%
(-0,025) 1D
14 қаз., 16:59:56 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for RYM...
Open
1,79 NZ$
High
1,82 NZ$
Low
1,75 NZ$
Mkt. cap
1,81 млрд
Avg. vol.
2,54 млн
Volume
1,86 млн
52-wk high
3,05 NZ$
52-wk low
1,66 NZ$
EPS
-0,17 NZ$
Shares outstanding
1,02 млрд
No. of employees
8 мың
Open
1,79 NZ$
High
1,82 NZ$
Low
1,75 NZ$
Mkt. cap
1,81 млрд
Avg. vol.
2,54 млн
Volume
1,86 млн
52-wk high
3,05 NZ$
52-wk low
1,66 NZ$
EPS
-0,17 NZ$
Shares outstanding
1,02 млрд
No. of employees
8 мың
News stories
From web sources and news partners
Profile
Ryman Healthcare Limited is a New Zealand retirement village and rest home operator. It is listed on the New Zealand Stock Exchange and was one of the largest companies listed on the NZX 50 Index. Ryman Healthcare has 48 operational villages across New Zealand and eight in Melbourne, and is developing further villages in New Zealand and Victoria. Its name is a portmanteau of its two founders, John Ryder and Kevin Hickman, who founded the company in 1984. As at June 2024, Ryman Healthcare has a market capitalisation of over $2.6 Billion NZD. Ryman's business model is a mixture of property development and healthcare services. It operates on a "deferred management fees" model where the village resident pays for a lifetime occupancy use of their apartment or unit, and upon moving out, the resident or their estate receives a lesser sum back for their unit, capped at 20% deducted if over a five-year period. Ryman Healthcare villages offer a blend of different retirement living options at their villages, which are usually large enough to support a mini-hospital for residents and a secure dementia wing. Wikipedia
About Ryman Healthcare Ltd
CEO-
Employees7,8 мың
Founded1984
Headquarters-
SectorHealth care provider
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
206,73 млн
206,73 млн
220,50 млн
220,50 млн
Cost of goods sold
188,46 млн
188,46 млн
198,38 млн
198,38 млн
Cost of revenue
188,46 млн
188,46 млн
198,38 млн
198,38 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
10,91 млн
10,91 млн
10,37 млн
10,37 млн
Total operating expenses
199,37 млн
199,37 млн
208,75 млн
208,75 млн
Operating income
7,36 млн
7,36 млн
11,75 млн
11,75 млн
Other non operating income
-
-
3,63 млн
3,63 млн
EBT including unusual items
-20,10 млн
-20,10 млн
-68,71 млн
-68,71 млн
EBT excluding unusual items
-20,50 млн
-20,50 млн
-18,06 млн
-18,06 млн
Income tax expense
2,50 млн
2,50 млн
-5,63 млн
-5,63 млн
Effective tax rate
-12,44%
-12,44%
8,20%
8,20%
Other operating expenses
-
-
-
-
Net income
-22,60 млн
-22,60 млн
-63,08 млн
-63,08 млн
Net profit margin
-10,93%
-10,93%
-28,61%
-28,61%
Earnings per share
-
-
-
-
Interest and investment income
156,00 м.
156,00 м.
403,50 м.
403,50 м.
Interest expense
-28,02 млн
-28,02 млн
-33,84 млн
-33,84 млн
Net interest expenses
-27,87 млн
-27,87 млн
-33,43 млн
-33,43 млн
Depreciation and amortization charges
10,91 млн
10,91 млн
10,37 млн
10,37 млн
EBITDA
18,27 млн
18,27 млн
20,69 млн
20,69 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары